Annexin A2 expression in head and neck squamous cell carcinoma;Expresión de la anexina A2 en los carcinomas epidermoides de cabeza y cuello

Acta Otorrinolaringologica Espanola

Volumn 58, Issue 6, 2007, Pages 257-262

  Rodrigo Tapia, Juan Pablo ^a,b   Pena Alonso, Emma ^a   García Pedrero, Juana M ^a   Florentino Fresno, Manuel ^b   Suárez Nieto, Carlos ^a,b   Owen Morgan, Reginald ^a   Pilar Fernández, María ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Annexin A2; Cancer; Expression; Head and neck

Indexed keywords

LIPOCORTIN 2; PARAFFIN;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; FEMALE; HEAD AND NECK CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRECANCER; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TUMOR DIFFERENTIATION;

EID: 34547893827     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-6519(07)74923-3     Document Type: Article

References (24)

1. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82:331-71.
2. Fernandez MP, Morgan RO. Structure, function and evolution of the annexin gene superfamily. En: Annexins: Biological importance and annexinrelated pathologies. Bandorowicz-Pikula J, editor. Georgetown: Landes Bioscience; 2003. p. 21-37.
3. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000;24:227-35.
4. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol. 2003;162:255-61.
5. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res. 2001;61:889-95.
6. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis. 2002;19:319-26.
7. Mai J, Waisman DM, Sloane BF. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta. 2000;1477:215-30.
8. Roseman BJ, Bollen A, Hsu J, Lamborn K, Israel MA. Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res. 1994;6:561-7.
9. Paciucci R, Tora M, Díaz VM, Real FX. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene. 1998;16:625-33.
10. Frohlich M, Motte P, Galvin K, Takahashi H, Wands J, Ozturk M. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol. 1990;10:3216-23.
11. Cole SP, Pinkoski MJ, Bhardwaj G, Deeley RG. Elevated expression of annexin II (lipocortin II, P36) in a multidrug resistant small cell lung cancer cell line. Br J Cancer. 1992;65:498-502.
12. Schwartz-Albiez R, Koretz K, Moller P, Wirl G. Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. Differentiation. 1993;52:229-37.
13. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, et al. Annexin II overexpression correlates with tenascin-C overexpression. A prognostic marker in colorectal carcinoma. Cancer. 2001;92:1419-26.
14. Chiang Y, Davis RG, Vishwanatha JK. Altered expression of annexin II in human B-cell lymphoma cell lines. Biochim Biophys Acta. 1996;1313:295-301.
15. Menell JS, Cesarman GM, Jacovina BS, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med. 1999;340:994-1004.
16. Liu JW, Shen JJ, Tanzillo-Swarts A, Maldonado CM, Person MD, Lau SS, et al. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene. 2003;22:1475-85.
17. Rodrigo JP, García Pedrero JM, Pena E, Fernández MP, Morgan RO, Suárez C, et al. Expresión de las anexinas A1 y A2 en la mucosa del tracto aerodigestivo superior. Acta Otorrinolaringol Esp. 2004;55:310-4.
18. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, et al. The EnVisionTM + system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMateTM, CSA, LABC and SABC techniques. J Clin Pathol. 1998;51:506-11.
19. Van Diest PJ, Van Dam P, Henzen-Logmans SC, Berns E, Van der Burg ME, Green J, et al. Ascoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. J Clin Pathol. 1997;50:801-4.
20. Califano J, Van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488-92.
21. Waisman DM. Annexin II tetramer: structure and function. Mol Cell Biochem. 1995;149:301-22.
22. Emoto K, Sawada H, Yamada Y, Fujimoto H, Takahama Y, Ueno M, et al. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res. 2001;21:1339-45.
23. Zhi H, Zhang J, Hu G, Lu J, Wang X, Zhou C, et al. The deregulation of arachidonic acid metabolism-related gen in human esophageal squamous cell carcinoma. Int J Cancer. 2003;106:327-33.
24. Rodrigo JP, Dominguez F, Alvarez C, Manrique C, Herrero A, Suárez C. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer. 2002;38:1059-64.